血必净注射液在颅脑损伤中的临床研究  

Clinical Research of Xuebijing Injection in Patients with Craniocerebral Injury

作　　者：李子坚[1] 林言华[1] 容耔耘[1] 

机构地区：[1]广东佛山市顺德第一人民医院神经外科,528300

出　　处：《岭南急诊医学杂志》2007年第4期263-264,共2页Lingnan Journal of Emergency Medicine

摘　　要：目的:探讨血必净注射液治疗颅脑损伤的疗效。方法:93例脑损伤患者随机分为两组,对照组47例常规治疗,治疗组46例在常规治疗的基础上辅以血必净注射液治疗,并比较其疗效。结果:治疗组的有效率明显高于对照组,降低NDS,降低肝、肾功能不全、心律失常和消化道出血的发生率,P均<0.01。结论:血必净辅助颅脑损伤的综合治疗可明显改善患者预后,降低并发症,值得临床推广。Objective: To investigate the therapeutic effect of Xuebijing injection on patients with craniocerebral injury. Methods: 93 patients with craniocerebral injury divided into control group(n=47) received regular treatment and treatment group(n=46) received added Xuebijing injection. The curative effects of two kinds of treatment were compared. Results: Companied with control group, the effective rate in treatment group was higher, neurologic impairment score, the incidence rate of hepatic 、renal inadequacy、arrhythmia and alimentary tract hemorrhage markedly reduced, all P < 0.01. Conclusions: The associated treatment of Xuebijing injection can improve prognosis and reduced complication, it should be adopted widely in the clinic healing of craniocerebral injury.

关 键 词：颅脑损伤 血必净 预后 

分 类 号：R651.15[医药卫生—外科学]